Asthma - Adults
|
Most Recent Report |
Past Reports |
Rate: 0%
* 2012 Report (7/1/2011-6/30/2012 DOS) (* Avg: 30%)
|
| |
Colorectal Cancer
|
Most Recent Report |
Past Reports |
Rate: 55%
* 2012 Report (7/1/2011-6/30/2012 DOS) (* Avg: 68%)
|
| Rate: 43%
* 2011 Report (7/1/2010-6/30/2011 DOS) (* Avg: 64%)
|
|
|
Utilization of the PHQ-9 |
Most Recent Report |
Legend  | Clinic Average |  | State Average |
|
Diabetes
|
Most Recent Report |
Past Reports |
Rate: 19%
* 2013 Report (2012 DOS) (* Avg: 38%)
|
| Rate: 17%
* 2012 Report (2011 DOS) (* Avg: 38%)
| Rate: 18%
* 2011 Report (2010 DOS) (* Avg: 37%)
| Rate: 3%
* 2010 Report (2009 DOS) (* Avg: 25%)
| Rate: 8%
* 2007 Report (* Avg: 14%)
|
|
|
Diabetes - Blood Pressure
|
Most Recent Report |
Past Reports |
Rate: 72%
* 2013 Report (2012 DOS) (* Avg: 84%)
|
| Rate: 73%
* 2012 Report (2011 DOS) (* Avg: 84%)
| Rate: 68%
* 2011 Report (2010 DOS) (* Avg: 83%)
| Rate: 25%
* 2010 Report (2009 DOS) (* Avg: 58%)
|
|
|
Diabetes - LDL Control
|
Most Recent Report |
Past Reports |
Rate: 47%
* 2013 Report (2012 DOS) (* Avg: 62%)
|
| Rate: 33%
* 2012 Report (2011 DOS) (* Avg: 62%)
| Rate: 47%
* 2011 Report (2010 DOS) (* Avg: 60%)
| Rate: 32%
* 2010 Report (2009 DOS) (* Avg: 57%)
|
|
|
Diabetes - HbA1c Control
|
Most Recent Report |
Past Reports |
Rate: 61%
* 2013 Report (2012 DOS) (* Avg: 74%)
|
| Rate: 67%
* 2012 Report (2011 DOS) (* Avg: 75%)
| Rate: 58%
* 2011 Report (2010 DOS) (* Avg: 75%)
| Rate: 65%
* 2010 Report (2009 DOS) (* Avg: 72%)
|
|
|
Diabetes - Tobacco-free
|
Most Recent Report |
Past Reports |
Rate: 84%
* 2013 Report (2012 DOS) (* Avg: 84%)
|
| Rate: 80%
* 2012 Report (2011 DOS) (* Avg: 84%)
| Rate: 77%
* 2011 Report (2010 DOS) (* Avg: 83%)
| Rate: 77%
* 2010 Report (2009 DOS) (* Avg: 83%)
|
|
|
Diabetes - Daily Aspirin Use
|
Most Recent Report |
Past Reports |
Rate: 100%
* 2013 Report (2012 DOS) (* Avg: 99%)
|
| Rate: 100%
* 2012 Report (2011 DOS) (* Avg: 99%)
| Rate: 100%
* 2011 Report (2010 DOS) (* Avg: 99%)
| Rate: 63%
* 2010 Report (2009 DOS) (* Avg: 86%)
|
|
|
Health Information Technology |
|
Vascular Disease
|
Most Recent Report |
Past Reports |
Rate: 29%
* 2013 Report (2012 DOS) (* Avg: 49%)
|
| Rate: 33%
* 2012 Report (2011 DOS) (* Avg: 49%)
| Rate: 26%
* 2011 Report (2010 DOS) (* Avg: 40%)
| Rate: 19%
* 2010 Report (2009 DOS) (* Avg: 34%)
| Rate: 16%
* 2009 Report (2008 DOS) (* Avg: 34%)
|
|
|
Vascular Disease - Blood Pressure
|
Most Recent Report |
Past Reports |
Rate: 76%
* 2013 Report (2012 DOS) (* Avg: 84%)
|
| Rate: 75%
* 2012 Report (2011 DOS) (* Avg: 84%)
| Rate: 59%
* 2011 Report (2010 DOS) (* Avg: 67%)
| Rate: 34%
* 2010 Report (2009 DOS) (* Avg: 58%)
| Rate: 30%
* 2009 Report (2008 DOS) (* Avg: 58%)
|
|
|
Vascular Disease - LDL Control
|
Most Recent Report |
Past Reports |
Rate: 48%
* 2013 Report (2012 DOS) (* Avg: 67%)
|
| Rate: 52%
* 2012 Report (2011 DOS) (* Avg: 67%)
| Rate: 62%
* 2011 Report (2010 DOS) (* Avg: 65%)
| Rate: 63%
* 2010 Report (2009 DOS) (* Avg: 64%)
| Rate: 51%
* 2009 Report (2008 DOS) (* Avg: 65%)
|
|
|
Vascular Disease - Tobacco-free
|
Most Recent Report |
Past Reports |
Rate: 85%
* 2013 Report (2012 DOS) (* Avg: 83%)
|
| Rate: 85%
* 2012 Report (2011 DOS) (* Avg: 83%)
| Rate: 87%
* 2011 Report (2010 DOS) (* Avg: 83%)
| Rate: 87%
* 2010 Report (2009 DOS) (* Avg: 81%)
| Rate: 79%
* 2009 Report (2008 DOS) (* Avg: 82%)
|
|
|
Vascular Disease - Daily Aspirin Use
|
Most Recent Report |
Past Reports |
Rate: 95%
* 2013 Report (2012 DOS) (* Avg: 96%)
|
| Rate: 97%
* 2012 Report (2011 DOS) (* Avg: 95%)
| Rate: 87%
* 2011 Report (2010 DOS) (* Avg: 94%)
| Rate: 89%
* 2010 Report (2009 DOS) (* Avg: 92%)
| Rate: 95%
* 2009 Report (2008 DOS) (* Avg: 93%)
|
|
|
